PRELIMINARY CONSULTATION: Australian Evidence-Based Clinical Guidelines for Diabetes

Published by Living Evidence for Diabetes Consortium on Dec 18, 2019

Disclaimer

These clinical guidelines are a general guide to appropriate practice, to be followed subject to the clinician’s judgement and the patient’s preference in each individual case. The guidelines are not intended to be proscriptive. They are designed to provide information to assist decision making and have been informed by the highest quality evidence available at the time of compilation. Accordingly, the parties involved in the development of these guidelines shall have no liability to any users of the information contained in this publication for any loss or damage, cost or expense incurred or arising from reliance on the information contained in this publication.   
 

Sponsors

Funding and in-kind support for the development of these clinical guidelines was provided by the Department of Health Chronic Disease Policy Section, Monash University Division of Metabolism, Ageing and Genomics, Australian Diabetes Society, Australian Diabetes Educators Association Cochrane, Diabetes Australia, Australian Paediatric Endocrine Group and Cochrane Australia.
 
 

Contact

Abstract

Language

en

PICOS

PICO 1.1

Population
Adults with type 1 diabetes
Intervention
CGM with alerts + MDI
Comparator
SMBG + MDI
Outcomes

PICO 1.2

Population
Adults with Type 1 diabetes
Intervention
CGM without alerts + MDI
Comparator
SMBG+MDI
Outcomes

PICO 1.3

Population
Adults with type 1 diabetes
Intervention
Flash + MDI
Comparator
SMBG + MDI
Outcomes

PICO 2.1

Population
PICO 6a - CSII vs MDI in children with type 1 diabetes
Intervention
CSII
Comparator
MDI
Outcomes

PICO 2.2

Population
Adults with Type 1 Diabetes
Intervention
Insulin Pump (CSII)
Comparator
Multiple Daily Injections (MDI)
Outcomes

PICO 3.1

Population
Tech PICO 3 CSII+CGM vs AutoCSII
Intervention
AutoCSII
Comparator
Control
Outcomes